IGHMBP2 is most highly expressed in the brain, and pathological symptoms of SMARD1 and CMT2S are restricted to neural and muscle tissue (Cox et al, 1998; Guenther et al, 2009b; Cottenie et al, 2014). Here, IGHMBP2 is linked to Charcot-Marie-Tooth disease axonal type 2S.